-
公开(公告)号:US20130230519A1
公开(公告)日:2013-09-05
申请号:US13817883
申请日:2011-08-12
IPC分类号: C07K16/18 , C07K14/605 , C07K14/56 , C07K16/46 , A61K47/48
CPC分类号: C07K16/18 , A61K47/6843 , C07K2317/21 , C07K2317/33 , C07K2317/565 , C07K2317/569 , C07K2317/90 , C07K2317/92
摘要: The invention relates to improved variants of the anti-serum albumin immunoglobulin single variable domain DOM7h-14-10, as well as ligands and drug conjugates comprising such variants, compositions, nucleic acids, vectors and hosts.
摘要翻译: 本发明涉及抗血清白蛋白免疫球蛋白单可变结构域DOM7h-14-10的改进变体,以及包含这些变体,组合物,核酸,载体和宿主的配体和药物偶联物。
-
公开(公告)号:US09040668B2
公开(公告)日:2015-05-26
申请号:US13698794
申请日:2011-05-20
IPC分类号: A61K39/395 , A61K39/00 , C12P21/08 , C07K14/765 , C07K19/00 , C07K16/46 , C07K16/18 , A61K47/48 , C07K16/28
CPC分类号: C07K16/18 , A61K47/6843 , A61K2039/505 , C07K14/765 , C07K16/2878 , C07K16/468 , C07K2317/21 , C07K2317/31 , C07K2317/565 , C07K2317/567 , C07K2317/569 , C07K2317/92 , C07K2317/94 , C07K2319/00 , C07K2319/31 , C07K2319/33
摘要: The invention relates to improved variants of the anti-serum albumin immunoglobulin single variable domain DOM7h-11, as well as ligands and drug conjugates comprising such variants, compositions, nucleic acids, vectors and hosts.
摘要翻译: 本发明涉及抗血清白蛋白免疫球蛋白单可变结构域DOM7h-11的改进变体,以及包含这些变体,组合物,核酸,载体和宿主的配体和药物偶联物。
-
公开(公告)号:US20130129746A1
公开(公告)日:2013-05-23
申请号:US13698794
申请日:2011-05-20
CPC分类号: C07K16/18 , A61K47/6843 , A61K2039/505 , C07K14/765 , C07K16/2878 , C07K16/468 , C07K2317/21 , C07K2317/31 , C07K2317/565 , C07K2317/567 , C07K2317/569 , C07K2317/92 , C07K2317/94 , C07K2319/00 , C07K2319/31 , C07K2319/33
摘要: The invention relates to improved variants of the anti-serum albumin immunoglobulin single variable domain DOM7h-11, as well as ligands and drug conjugates comprising such variants, compositions, nucleic acids, vectors and hosts.
-
公开(公告)号:US08779103B2
公开(公告)日:2014-07-15
申请号:US13256957
申请日:2010-03-24
申请人: Christopher Herring , Lucy J. Holt , Laurent S. Jespers , Sebastian Mayer , Malgorzata Pupecka-Swider
发明人: Christopher Herring , Lucy J. Holt , Laurent S. Jespers , Sebastian Mayer , Malgorzata Pupecka-Swider
IPC分类号: C12P21/08 , A61K39/395 , C07K16/46 , C07K14/575 , C12N15/62 , A61P3/00 , A61P3/04 , A61P3/08
CPC分类号: C07K14/605 , A61K38/26 , A61K39/3955 , A61K47/6803 , A61K47/6843 , C07K16/18 , C07K2317/21 , C07K2317/569
摘要: The present invention relates to drug fusions that have improved serum half lives. These fusions and conjugates comprise polypeptides, immunoglobulin (antibody) single variable domains and GLP and/or exendin molecules. The invention further relates to uses, formulations, compositions and devices comprising such drug fusions and conjugates.
摘要翻译: 本发明涉及具有改善的血清半衰期的药物融合物。 这些融合物和缀合物包含多肽,免疫球蛋白(抗体)单可变结构域和GLP和/或毒蜥外泌肽分子。 本发明还涉及包含这种药物融合物和缀合物的用途,制剂,组合物和装置。
-
-
-